HTL Biotechnology joins the Choiseul Conquérants 2025 ranking
HTL Biotechnology is recognized for the second consecutive year among France’s most dynamic and innovative mid-sized companies.
This new edition marks an important milestone in our sustainability journey. It captures the concrete initiatives, strategic choices, and collective energy that have shaped our year. From reducing our environmental footprint to promoting diversity and inclusion, and strengthening dialogue with our stakeholders — every step we’ve taken is part of a long-term vision.
Discover the path HTL Biotechnology is taking to shape a more responsible and innovative future.
Happy reading!
HTL Biotechnology is recognized for the second consecutive year among France’s most dynamic and innovative mid-sized companies.
On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.
This October, HTL Biotechnology turned pink to support breast cancer prevention.